Una de las mayores metas de Life4me+ — prevenir nuevos casos de VIH y otras ITS, hepatitis C y tuberculosis.

El app ayuda a establecer una comunicación anónima entre médicos y personas vih+. Te permite organizar tu horario de toma de tratamiento de manera conveniente y fijar recordatorios personalizados que se pueden ocultar.

Todas las noticias / Noviembre 2019

Archivo

✕

13 noviembre 2019

8656

#NoHIVStigma demonstration takes to the streets of Basel

#NoHIVStigma demonstration takes to the streets of Basel

Activists, advocates, and people living with HIV from across the world took part in the NoHIVStigma demonstration in Basel on Friday night. The message was clear "No to stigma, Yes to solidarity". The demonstration was the climax of a week long NoHIVStigma campaign across ...

8 noviembre 2019

7025

SIMPL'HIV Study data backs another dual therapy option

SIMPL'HIV Study data backs another dual therapy option

Dual therapy for HIV is increasingly becoming a viable option for more and more people and the results from Switzerland's SIMPL'HIV study only add more weight to the viability of dual therapy choices. The SIMPL'HIV study was an open-label, non-inferiority randomized trial ...

7 noviembre 2019

6668

Are integrase inhibitors causing weight gain?

Are integrase inhibitors causing weight gain?

For some time now there's been anecdotal evidence that a certain class of HIV treatment, known as integrase inhibitors, could be causing weight gain. Today, Thursday 7th November 2019, HIV doctors from around the world shared their data at the European AIDS Clinical Society ...

7 noviembre 2019

6705

New HIV Drugs: Who needs them?

New HIV Drugs: Who needs them?

Professor Chloe Orkin of the British HIV Association (BHIVA) updated European AIDS Clinical Society (EACS) delegates with an exciting update on the latest drugs and treatment methods in development. These range from new daily pills through to long lasting injectables, ...

6 noviembre 2019

6568

Broadly Neutralising Antibodies: The future of HIV care?

Broadly Neutralising Antibodies: The future of HIV care?

The HIV community came together at the EACS conference in Basel to discuss the pathway to achieving long-term remission of HIV. It's important to point out that we're using the term 'long-term remission' rather than 'cure' because cure is a word that has many meanings ...

6 noviembre 2019

6000

PrEP for Women: Still massive gaps

PrEP for Women: Still massive gaps

At the European AIDS Clinical Society (EACS) conference in Basel, Switzerland, the group Women Against Viruses in Europe (WAVE) presented the findings of their survey on women accessing PrEP. The data showed that whilst there is now wider access to PrEP many women still ...